Johnson and Johnson: Shockwave Medical Completes Enrollment in All-Female Coronary IVL Study
October 29, 2024
October 29, 2024
NEW BRUNSWICK, New Jersey, Oct. 29 (TNSres) -- Johnson and Johnson issued the following news release:
* * *
The first prospective female-only study of coronary interventions in complex calcific disease, EMPOWER CAD aims to confirm benefits of Shockwave intravascular lithotripsy in women
Co-Principal Investigator Margaret McEntegart, MD, completed enrollment during a live case at this year's Transcatheter Cardiovascular Therapeutics (TCT) Conference in Washi . . .
* * *
The first prospective female-only study of coronary interventions in complex calcific disease, EMPOWER CAD aims to confirm benefits of Shockwave intravascular lithotripsy in women
Co-Principal Investigator Margaret McEntegart, MD, completed enrollment during a live case at this year's Transcatheter Cardiovascular Therapeutics (TCT) Conference in Washi . . .